Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 5(54), p. 2262-2264, 2010

DOI: 10.1128/aac.01423-09

Links

Tools

Export citation

Search in Google Scholar

Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

ABSTRACT Murine models of M ycobacterium tuberculosis infection are essential tools in drug discovery. Here we describe a fast standardized 9-day acute assay intended to measure the efficacy of drugs against M. tuberculosis growing in the lungs of immunocompetent mice. This assay is highly reproducible, allows good throughput, and was validated for drug lead optimization using isoniazid, rifampin, ethambutol, pyrazinamide, linezolid, and moxifloxacin.